Evidence-Based Risk Management: How Can We Succeed?: Deliberations from a Risk Management Advisory Council-Reference-Cited by-同舟云学术

Evidence-Based Risk Management: How Can We Succeed?: Deliberations from a Risk Management Advisory Council

Published:2003-01 Issue:1 Volume:37 Page:127-134
ISSN:0092-8615
Container-title:Drug Information Journal
language:en
Short-container-title:Drug Information J

Author:

Perfetto Eleanor M.,Ellison Russell,Ackermann Susan,Sherr Marjorie,Zaugg Ana Maria

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug Guides,Pharmacology (nursing)

Link

http://link.springer.com/content/pdf/10.1177/009286150303700115.pdf

Reference8 articles.

1. Anonymous. Office of Drug Safety Annual Report. Center for Drug Evaluation and Research 2001. http://www.fda.gov/cder/Offices/ODS/annrep2001/annualreport2001.htm. (Accessed on 09/27/02.)

2. Hubbard WK. Drug Safety and Risk Management; Notice of Meeting. Federal Register. 2002 July 11; 63(133).

3. US Department of Health and Human Services. PDUFA Reauthorization Good For American Patients. HHS News. June 18, 2002.

4. Butler. Mary Ellen. Congress Reauthorizes PDUFA. US Medicine Institute for Health Studies. July; 1, 2002.

5. Centers for Education and Research on Therapeutics. Overview: Fact Sheet. http://www.ahcpr.gov/clinic/certsovr.htm. (Accessed on 10/01/02)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Communication and the Pharmaceutical Industry;Drug Safety;2012-11

2. Drug Safety Proposals And The Intrusion Of Federal Regulation Into Patient Freedom And Medical Practice;Health Affairs;2007-05

3. Disturbance of vision by COX-2 inhibitors;Expert Opinion on Drug Safety;2004-11

4. Managing the Interface with Marketing to Improve Delivery of Pharmacovigilance Within the Pharmaceutical Industry;Drug Safety;2004

5. The Dawn of Pharmacovigilance;International Journal of Pharmaceutical Medicine;2003